Publication | Closed Access

A randomized trial in patients undergoing percutaneous coronary angioplasty: Roxithromycin does not reduce clinical restenosis but angioplasty increases antibody concentrations against Chlamydia pneumoniae

Percutaneous Coronary InterventionAntibioticsCardiovascular DiseaseClinical RestenosisClinical InfectionRandomized TrialMedicineChlamydia PneumoniaeEmergency MedicineCoronary Artery Disease